7 Results for "

Microtubule degradation

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Microtubule degradation" in MCE Product Catalog:

Cat. No.: HY-178960
Research Areas:  

Cancer

Tubulin-IN-59 (Compound 8g) is an orally active Tubulin inhibitor. Tubulin-IN-59 exhibits potent anti-proliferative activity against HCT116 colorectal cancer, HeLa cervical cancer, and HepG2 liver cancer cell lines, with its IC₅₀ value ranging from 16 to 35 nM. Tubulin-IN-59 arrests HeLa cells in the G2/M phase and induces cell apoptosis. Tubulin-IN-59 demonstrates significant anti-tumor activity in the HT29 human colon cancer mouse xenograft model. Tubulin-IN-59 can be used for the study of colorectal cancer and cervical cancer .
loading...
    loading...
Cat. No.: HY-155196
CAS No.: 2922929-62-0
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

ER degrader 6 (compound 35s) is a potent Estrogen Receptor (ER)α degrader. ER degrader 6 disrupts the microtubule network by restraining tubulin polymerization. ER degrader 6 suppresses tumor growth without noticeable poisonousness .
loading...
    loading...
Cat. No.: HY-155197
CAS No.: 2922929-63-1
Research Areas:  

Cancer

ER degrader 7 is an estrogen receptor α (ERα) degrader and a tubulin (tubulin) inhibitor. ER degrader 7 inhibits the cell viability of various cancer cell lines. ER degrader 7 disrupts the microtubule network in breast cancer cells, induces G2/M phase cell cycle arrest, and exhibits concentration-dependent accumulation in Tamoxifen-resistant LCC2 cells. ER degrader 7 suppresses tumor growth in vivo without causing body weight loss. ER degrader 7 can be applied in studies related to breast cancer .
loading...
    loading...
Cat. No.: HY-161324
Research Areas:  

Cancer

Tubulin degrader 1, a derivative of BML284 (HY-19987), is an orally active Tubulin degrader with anti-tumor cell proliferation activity. Tubulin degrader 1 binds to the colchicine-binding site of β-tubulin, inhibits tubulin polymerization and promotes tubulin degradation. Tubulin degrader 1 inhibits microtubule polymerization, induces G2/M cell cycle arrest and apoptosis. Tubulin degrader 1 suppresses tumor growth in ovarian cancer xenograft models, induces anti-proliferative activity against tumor cells and overcomes multidrug resistance. Tubulin degrader 1 can be used in research related to various cancers including ovarian cancer .
loading...
    loading...
Cat. No.: HY-161641
Target:  

HyT Microtubule/Tubulin

Research Areas:  

Cancer

Tubulin degrader 2 is a tubulin HyT degrader and tubulin polymerization inhibitor, with a DC50 of 4.9 μM against α-tubulin in MCF-7 cells and an IC50 of 7.5 μM for the polymerization of purified recombinant tubulin. Tubulin degrader 2 binds to the colchicine-binding site of tubulin, induces proteasome-dependent degradation of α-tubulin and β-tubulin, inhibits the polymerization of purified recombinant tubulin, and triggers microtubule disruption and cell cycle arrest in cancer cells. Tubulin degrader 2 exhibits antitumor activity in a breast cancer allograft mouse model. Tubulin degrader 2 can be applied in the research of breast cancer, lung cancer, and colorectal cancer .
loading...
    loading...
Cat. No.: HY-174148
Research Areas:  

Cancer

Anion transporter-4 (Compound 6) is a small-molecule anion transporter, which induces tubulin degradation and mitochondrial dysfunction. Anion transporter-4 can increase intracellular anion levels such as chloride ions by disrupting microtubule dynamics, promoting lipid peroxidation, and impairing mitochondrial function. Anion transporter-4 triggers ferroptosis to exert anticancer activity. Anion transporter-4 is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-D3153
CAS No.: 2693397-68-9
PbQ is a tubulin inhibitor (with an IC50 of 5 μM against goat tubulin) and a fluorescent probe for cuprous ions Cu (I). PbQ can penetrate the membrane of peripheral blood mononuclear cells, form a stable 1:1 complex with Cu + ions, and exhibits low toxicity and good biocompatibility toward macrophage cell lines. In addition, PbQ promotes tubulin degradation and disrupts the microtubule network in lung epithelial cells without affecting actin. PbQ also possesses genotoxicity by forming DNA base adducts, and it can activate caspase-3 and apoptosis-related genes, induce loss of mitochondrial membrane potential, and trigger cell apoptosis. PbQ can be used in studies related to chronic obstructive pulmonary disease .
loading...
    loading...